About Lykon
Lykon is a company based in Berlin (Germany) founded in 2015 by Tobias Teuber and Hans Gert Stuke was acquired by Lifesum in June 2024. Lykon has raised $20.51 million across 4 funding rounds from investors including Lifesum, European Union and ZINTINUS. Lykon has completed 1 acquisition, including Gaia Nutrition. Lykon offers products and services including At-Home Health Tests, Personalized Nutrition Plans, and Health Supplements. Lykon operates in a competitive market with competitors including Kenkodo, midge medical, memido, HIV-Selbsttest and DNAid Diagnostics, among others.
- Headquarter Berlin, Germany
- Founders Tobias Teuber, Hans Gert Stuke
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Lykon
Lykon offers a comprehensive portfolio of products and services, including At-Home Health Tests, Personalized Nutrition Plans, and Health Supplements.
Kits for self-testing health metrics and receiving personalized recommendations.
Custom dietary advice based on test results for improved well-being.
Products designed for digestion, weight loss, and vitality enhancement.
People of Lykon
Unlock access to complete
Founder Team
1 people
QM/RA Team
1 people
Leadership Team
1 people
Product Management Team
1 people
Unlock access to complete
Funding Insights of Lykon
Lykon has successfully raised a total of $20.51M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $2.72 million completed in August 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series A — $2.7M
-
First Round
First Round
(01 Jan 2019)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2023 | Amount | Series A - Lykon | Valuation | Zintinus |
|
| Sep, 2022 | Amount | Series A - Lykon | Valuation | Zintinus | |
| Jun, 2021 | Amount | Seed - Lykon | Valuation | Redstone , Ippen Media |
|
Investors in Lykon
Lykon has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Lifesum, European Union and ZINTINUS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital funding is offered for Food Tech innovations.
|
Founded Year | Domain | Location | |
|
Venture Debt is offered by Bridge to Growth for tech firms.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
Investments & Acquisitions by Lykon
Lykon has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Gaia Nutrition.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Mobile-based application offering fitness and nutrition training
|
2017 |
Financial Statements - Lykon
Lykon Comparisons
Competitors of Lykon
Lykon operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kenkodo, midge medical, memido, HIV-Selbsttest and DNAid Diagnostics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Diagnostic kit and app to track body metabolism
|
|
| domain | founded_year | HQ Location |
Midge Medical operates an online platform supplying diagnostic testing kits for healthcare needs.
|
|
| domain | founded_year | HQ Location |
Offers at-home urine test kits for health analysis.
|
|
| domain | founded_year | HQ Location |
Provides a mobile application for ordering HIV self-diagnosis test kits.
|
|
| domain | founded_year | HQ Location |
Operates a diagnostic lab for detecting cancer through blood tests.
|
Frequently Asked Questions about Lykon
Lykon was founded in 2015 and raised its 1st funding round 4 years after it was founded.
Lykon is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.
Tobias Teuber is the current CEO of Lykon. They have also founded this company.
Lykon is a funded company, having raised a total of $20.51M across 4 funding rounds to date. The company's 1st funding round was a Seed of $7.75M, raised on Jan 01, 2019.
Online platform for preventive care testing. Users can order the tests online which include sample kits to collect blood samples at home. The company analyzes the blood and prepares customized reports along with personal recommendations. Users can use the services for a range of needs including Vitamin D testing, fitness recommendations, and nutrition screening among others.
Lykon's top competitors include Kenkodo, midge medical and memido.
Lykon offers At-Home Health Tests, Personalized Nutrition Plans, and Health Supplements.
Lykon has made 1 acquisition, including Gaia Nutrition.
Lykon has 7 investors. Key investors include Lifesum, European Union, ZINTINUS, Bridge to Growth, and MA Ventures.